Liquefaction of semen generates and later degrades a conserved semenogelin peptide that enhances HIV infection

Journal of Virology

Volumn 88, Issue 13, 2014, Pages 7221-7234

  Roan, Nadia R ^a,b   Liu, Haichuan ^c   Usmani, Shariq M ^d   Neidleman, Jason ^a   Müller, Janis A ^d   Avila Herrera, Aram ^e   Gawanbacht, Ali ^d   Zirafi, Onofrio ^d   Chu, Simon ^a   Dong, Ming ^f   Kumar, Senthil T ^g   Smith, James F ^b   Pollard, Katherine S ^b,e   Fändrich, Marcus ^g   Kirchhoff, Frank ^d   Münch, Jan ^d   Witkowska, H Ewa ^c   Greene, Warner C ^a,c  

^a GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^f LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^g UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; SEMENOGELIN 1 (86-107); SERINE PROTEINASE; SPERM ANTIGEN; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT; SEMINAL VESICLE SECRETORY PROTEIN; SEMINAL VESICLE-SPECIFIC ANTIGEN;

ARTICLE; BINDING ASSAY; CONTROLLED STUDY; EJACULATION; ENZYME ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LIQUEFACTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; SEMEN ANALYSIS; SPERM; VIRUS ACTIVATION; VIRUS ATTACHMENT; VIRUS TRANSMISSION; AMINO ACID SEQUENCE; CHEMISTRY; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MOLECULAR GENETICS; PHYLOGENY; PHYSIOLOGY; SEQUENCE HOMOLOGY; VIROLOGY; VIRUS ENTRY; WESTERN BLOTTING;

AMINO ACID SEQUENCE; AMYLOID; BLOTTING, WESTERN; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHYLOGENY; PROTEOLYSIS; SEMEN; SEMINAL VESICLE SECRETORY PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; VIRUS INTERNALIZATION;

EID: 84901429692     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00269-14     Document Type: Article

References (32)

1. de Lamirande E. 2007. Semenogelin, the main protein of the human semen coagulum, regulates sperm function. Semin. Thromb. Hemost. 33:60-68. http://dx.doi.org/10.1055/s-2006-958463.
2. Taylor U, Rath D, Zerbe H, Schuberth HJ. 2008. Interaction of intact porcine spermatozoa with epithelial cells and neutrophilic granulocytes during uterine passage. Reprod. Domest. Anim. 43:166-175. http://dx .doi.org/10.1111/j.1439-0531.2007.00872.x.
3. Lilja H, Oldbring J, Rannevik G, Laurell CB. 1987. Seminal vesiclesecreted proteins and their reactions during gelation and liquefaction of human semen. J. Clin. Invest. 80:281-285. http://dx.doi.org/10.1172 /JCI113070.
4. Robert M, Gibbs BF, Jacobson E, Gagnon C. 1997. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I. Biochemistry 36:3811-3819. http://dx.doi.org/10.1021/bi9626158.
5. Koistinen H, Soini T, Leinonen J, Hyden-Granskog C, Salo J, Halttunen M, Stenman UH, Seppala M, Koistinen R. 2002. Monoclonal antibodies, immunofluorometric assay, and detection of human semenogelin in male reproductive tract: no association with in vitro fertilizing capacity of sperm. Biol. Reprod. 66:624-628. http://dx.doi .org/10.1095/biolreprod66.3.624.
6. Kingan SB, Tatar M, Rand DM. 2003. Reduced polymorphism in the chimpanzee semen coagulating protein, semenogelin I. J. Mol. Evol. 57: 159-169. http://dx.doi.org/10.1007/s00239-002-2463-0.
7. Dorus S, Evans PD, Wyckoff GJ, Choi SS, Lahn BT. 2004. Rate of molecular evolution of the seminal protein gene SEMG2 correlates with levels of female promiscuity. Nat. Genet. 36:1326-1329. http://dx.doi.org /10.1038/ng1471.
8. Roan NR, Muller JA, Liu H, Chu S, Arnold F, Sturzel CM, Walther P, Dong M, Witkowska HE, Kirchhoff F, Munch J, Greene WC. 2011. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe 10:541-550. http://dx.doi.org/10.1016/j.chom.2011.10.010.
9. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, Gimenez-Gallego G, Sanchez PC, Fowler DM, Koulov A, Kelly JW, Mothes W, Grivel JC, Margolis L, Keppler OT, Forssmann WG, Kirchhoff F. 2007. Semenderived amyloid fibrils drastically enhance HIV infection. Cell 131:1059-1071. http://dx.doi.org/10.1016/j.cell.2007.10.014.
10. Roan NR, Munch J, Arhel N, Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, Greene WC. 2009. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J. Virol. 83:73-80. http://dx.doi.org/10.1128/JVI.01366-08.
11. Roan NR, Sowinski S, Munch J, Kirchhoff F, Greene WC. 2010. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). J. Biol. Chem. 285:1861-1869. http://dx.doi.org/10 .1074/jbc.M109.066167.
12. Bouhlal H, Chomont N, Haeffner-Cavaillon N, Kazatchkine MD, Belec L, Hocini H. 2002. Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells. J. Immunol. 169:3301-3306. http://dx.doi.org/10.4049/jimmunol.169.6.3301.
13. Hauber I, Hohenberg H, Holstermann B, Hunstein W, Hauber J. 2009. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Proc. Natl. Acad. Sci. U. S. A. 106:9033-9038. http://dx.doi.org/10.1073/pnas.0811827106.
14. Kim KA, Yolamanova M, Zirafi O, Roan NR, Staendker L, Forssmann WG, Burgener A, Dejucq-Rainsford N, Hahn BH, Shaw GM, Greene WC, Kirchhoff F, Munch J. 2010. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 7:55. http://dx.doi.org/10.1186/1742-4690-7-55.
15. Olsen JS, Brown C, Capule CC, Rubinshtein M, Doran TM, Srivastava RK, Feng C, Nilsson BL, Yang J, Dewhurst S. 2010. Amyloidbinding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)-and semen-mediated enhancement of HIV-1 infection. J. Biol. Chem. 285:35488-35496. http://dx.doi.org /10.1074/jbc.M110.163659.
16. Arnold F, Schnell J, Zirafi O, Sturzel C, Meier C, Weil T, Standker L, Forssmann WG, Roan NR, Greene WC, Kirchhoff F, Munch J. 2011. Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection. J. Virol. 86:1244-1249. http://dx.doi.org/10.1128/JVI.06121-11.
17. Linke RP, Joswig R, Murphy CL, Wang S, Zhou H, Gross U, Rocken C, Westermark P, Weiss DT, Solomon A. 2005. Senile seminal vesicle amyloid is derived from semenogelin I. J. Lab. Clin. Med. 145:187-193. http://dx.doi.org/10.1016/j.lab.2005.02.002.
18. Giehm L, Otzen DE. 2010. Strategies to increase the reproducibility of protein fibrillization in plate reader assays. Anal. Biochem. 400:270-281. http://dx.doi.org/10.1016/j.ab.2010.02.001.
19. Cavrois M, De Noronha C, Greene WC. 2002. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20:1151-1154. http://dx.doi.org/10.1038 /nbt745.
20. Kanu AB, Dwivedi P, Tam M, Matz L, Hill HH, Jr. 2008. Ion mobilitymass spectrometry. J. Mass Spectrom. 43:1-22. http://dx.doi.org/10.1002 /jms.1383.
21. Mitra A, Richardson RT, O'Rand MG. 2010. Analysis of recombinant human semenogelin as an inhibitor of human sperm motility. Biol. Reprod. 82:489-496. http://dx.doi.org/10.1095/biolreprod.109.081331.
22. Hamilton RL, Jr, Goerke J, Guo LS, Williams MC, Havel RJ. 1980. Unilamellar liposomes made with the French pressure cell: a simple preparative and semiquantitative technique. J. Lipid Res. 21:981-992.
23. Usmani S, Zirafi O, Muller JA, Sandi-Monroy NL, Yadav JK, Meier C, Weil T, Roan NR, Greene WC, Walther P, Nilsson KP, Hammarstrom P, Wetzel R, Pilcher CD, Gagsteiger F, Fandrich M, Kirchhoff F, Munch J. 2014. Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen. Nat. Commun. 5:3508. http://dx.doi.org/10.1038 /ncomms4508.
24. Jonsson M, Linse S, Frohm B, Lundwall A, Malm J. 2005. Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen. Biochem. J. 387:447-453. http://dx.doi.org/10.1042/BJ20041424.
25. Goldschmidt L, Teng PK, Riek R, Eisenberg D. 2010. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc. Natl. Acad. Sci. U. S. A. 107:3487-3492. http://dx.doi.org/10.1073/pnas .0915166107.
26. Hurle B, Swanson W, Green ED. 2007. Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage. Genome Res. 17:276-286. http://dx.doi.org/10.1101/gr .6004607.
27. Rubinsztein DC, Carmichael J. 2003. Huntington's disease: molecular basis of neurodegeneration. Expert Rev. Mol. Med. 5:1-21. http://dx.doi .org/10.1017/S1462399403006549.
28. Lundwall A, Brattsand M. 2008. Kallikrein-related peptidases. Cell. Mol. Life Sci. 65:2019-2038. http://dx.doi.org/10.1007/s00018-008-8024-3.
29. Robert M, Gagnon C. 1994. Sperm motility inhibitor from human seminal plasma: presence of a precursor molecule in seminal vesicle fluid and its molecular processing after ejaculation. Int. J. Androl. 17:232-240. http: //dx.doi.org/10.1111/j.1365-2605.1994.tb01248.x.
30. Emami N, Deperthes D, Malm J, Diamandis EP. 2008. Major role of human KLK14 in seminal clot liquefaction. J. Biol. Chem. 283:19561-19569. http://dx.doi.org/10.1074/jbc.M801194200.
31. Hu J, Gardner MB, Miller CJ. 2000. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74:6087-6095. http: //dx.doi.org/10.1128/JVI.74.13.6087-6095.2000.
32. Hartjen P, Frerk S, Hauber I, Matzat V, Thomssen A, Holstermann B, Hohenberg H, Schulze W, Schulze Zur Wiesch J, van Lunzen J. 2012. Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG. AIDS Res. Ther. 9:2. http://dx.doi.org/10.1186/1742-6405-9-2.